These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17221852)

  • 21. Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: incidence, risk factors, management, and clinical sequelae.
    Saxena A; Chua TC; Yan TD; Morris DL
    Ann Surg Oncol; 2010 May; 17(5):1302-10. PubMed ID: 20087784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peritonectomy and intraperitoneal chemotherapy--new methods in multi-modality therapy of peritoneal carcinosis].
    Jähne J; Piso P
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1435-7. PubMed ID: 9931904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
    Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
    J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis.
    Spiliotis J; Rogdakis A; Vaxevanidou A; Datsis A; Zacharis G; Christopoulou A
    J BUON; 2009; 14(2):259-64. PubMed ID: 19650176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach.
    Sugarbaker PH
    Expert Opin Pharmacother; 2009 Aug; 10(12):1965-77. PubMed ID: 19563273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer.
    Stamou KM; Karakozis S; Sugarbaker PH
    J Surg Oncol; 2003 Aug; 83(4):197-203. PubMed ID: 12884230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.
    Hansson J; Graf W; Påhlman L; Nygren P; Mahteme H
    Eur J Surg Oncol; 2009 Feb; 35(2):202-8. PubMed ID: 18514475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.
    Begossi G; Gonzalez-Moreno S; Ortega-Perez G; Fon LJ; Sugarbaker PH
    Eur J Surg Oncol; 2002 Feb; 28(1):80-7. PubMed ID: 11869020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
    Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
    J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].
    Iesalnieks I; Kullmann F; Dahlke M; Ghali N; Agha A; von Breitenbuch P; Schoelmerich J; Schlitt HJ; Piso P
    Z Gastroenterol; 2006 Dec; 44(12):1237-45. PubMed ID: 17163375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center.
    Gusani NJ; Cho SW; Colovos C; Seo S; Franko J; Richard SD; Edwards RP; Brown CK; Holtzman MP; Zeh HJ; Bartlett DL
    Ann Surg Oncol; 2008 Mar; 15(3):754-63. PubMed ID: 18080166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical responsibilities in the management of peritoneal carcinomatosis.
    Sugarbaker PH
    J Surg Oncol; 2010 Jun; 101(8):713-24. PubMed ID: 20512948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
    Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.
    Mahteme H; Sugarbaker PH
    Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
    Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
    Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for massive blood transfusion in cytoreductive surgery: a multivariate analysis of 243 procedures.
    Saxena A; Yan TD; Chua TC; Fransi S; Almohaimeed K; Ahmed S; Morris DL
    Ann Surg Oncol; 2009 Aug; 16(8):2195-203. PubMed ID: 19408046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
    Chua TC; Koh JL; Yan TD; Liauw W; Morris DL
    J Surg Oncol; 2009 Aug; 100(2):139-43. PubMed ID: 19544356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.